Oscar Health, Inc. (OSCR)
USD 13.2
(1.15%)
USD 13.2
(1.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -235.61 Million USD | 59.67% |
| 2022 | -584.17 Million USD | -1.23% |
| 2021 | -577.06 Million USD | -41.83% |
| 2020 | -406.86 Million USD | -56.21% |
| 2019 | -260.46 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 185.55 Million USD | 227.55% |
| 2024 Q2 | 67.81 Million USD | -63.46% |
| 2023 Q3 | -58.24 Million USD | -792.08% |
| 2023 FY | -235.61 Million USD | 59.67% |
| 2023 Q4 | -145.47 Million USD | -149.77% |
| 2023 Q2 | -6.52 Million USD | 78.45% |
| 2023 Q1 | -30.3 Million USD | 86.26% |
| 2022 Q2 | -106.48 Million USD | -53.41% |
| 2022 Q1 | -69.41 Million USD | 65.05% |
| 2022 FY | -584.17 Million USD | -1.23% |
| 2022 Q4 | -220.62 Million USD | -19.15% |
| 2022 Q3 | -185.17 Million USD | -73.89% |
| 2021 Q4 | -198.63 Million USD | 6.72% |
| 2021 Q3 | -212.94 Million USD | -194.73% |
| 2021 Q2 | -72.25 Million USD | -15.54% |
| 2021 FY | -577.06 Million USD | -41.83% |
| 2021 Q1 | -62.53 Million USD | 66.53% |
| 2020 FY | -406.86 Million USD | -56.21% |
| 2020 Q4 | -186.83 Million USD | -133.17% |
| 2020 Q2 | -39.35 Million USD | 58.99% |
| 2020 Q1 | -95.94 Million USD | 0.0% |
| 2020 Q3 | -80.13 Million USD | -103.63% |
| 2019 FY | -260.46 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cigna Corporation | 8.53 Billion USD | 102.76% |
| Centene Corporation | 2.93 Billion USD | 108.041% |
| CVS Health Corporation | 13.74 Billion USD | 101.714% |
| Elevance Health Inc. | 133.96 Billion USD | 100.176% |
| Humana Inc. | 4.01 Billion USD | 105.871% |
| Molina Healthcare, Inc. | 1.57 Billion USD | 114.979% |
| UnitedHealth Group Incorporated | 32.35 Billion USD | 100.728% |